Inventiva S.A. Q4 2023 Earnings Call Transcript

IVA Stock  USD 2.65  0.03  1.12%   
About 61% of Inventiva's investor base is looking to short. The analysis of the overall investor sentiment regarding Inventiva Sa suggests that many traders are alarmed. The current market sentiment, together with Inventiva's historical and current headlines, can help investors time the market. In addition, many technical investors use Inventiva Sa stock news signals to limit their universe of possible portfolio assets.
  
Operator Good day and thank you for standing by. Welcome to the Inventiva Annual Results 2023 conference call. At this time, all participants are in a listen-only mode.

Read at insidermonkey.com
insidermonkey News
  

Inventiva Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Inventiva can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Inventiva Fundamental Analysis

We analyze Inventiva's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inventiva using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inventiva based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Operating Margin

Operating Margin Comparative Analysis

Inventiva is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Inventiva Sa Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Inventiva stock to make a market-neutral strategy. Peer analysis of Inventiva could also be used in its relative valuation, which is a method of valuing Inventiva by comparing valuation metrics with similar companies.

Peers

Inventiva Related Equities

GLUEMonte Rosa   13.72   
0%
100.0%
VIGLVigil Neuroscience   7.39   
0%
53.0%
CMPXCompass Therapeutics   4.49   
0%
32.0%
VRCAVerrica Pharmaceuticals   3.23   
0%
23.0%
CGEMCullinan Oncology   2.75   
0%
20.0%
IPHAInnate Pharma   2.67   
0%
19.0%
EWTXEdgewise Therapeutics   2.48   
0%
18.0%
VTYXVentyx Biosciences   1.13   
0%
8.0%
RZLTRezolute   1.00   
0%
7.0%
ANEBAnebulo Pharmaceuticals   0.70   
0%
5.0%
PCVXVaxcyte   0.38   
0%
2.0%
IMCRImmunocore Holdings   0.27   
1.0%
0%
ACLXArcellx   1.12   
8.0%
0%
ELYMEliem Therapeutics   1.30   
9.0%
0%
INBXInhibrx   2.37   
17.0%
0%
JANXJanux Therapeutics   2.54   
18.0%
0%
MLYSMineralys Therapeutics,   2.59   
18.0%
0%
NAMSNewAmsterdam Pharma   4.57   
33.0%
0%
HCWBHCW Biologics   6.00   
43.0%
0%

Complementary Tools for Inventiva Stock analysis

When running Inventiva's price analysis, check to measure Inventiva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inventiva is operating at the current time. Most of Inventiva's value examination focuses on studying past and present price action to predict the probability of Inventiva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inventiva's price. Additionally, you may evaluate how the addition of Inventiva to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets